Live
- PKL Season 11: U Mumbai meet UP Yoddhas in opening clash of exciting second leg in Noida
- Cong divides people on caste & religion lines for political gains: Shahnawaz Hussain
- Pushpa-2: The Rule to Launch Grand Promotional Tour Across Seven Indian Cities
- Maha polls: Congress accuses BJP of pursuing ‘divide and cut’ policy to divert attention
- His currency supply has ended: Ashwini Choubey's jibe at Tejashwi
- Avoid challenging constitutional institutions: VP Dhankhar
- Maha polls: BJP hurls questions at INDIA bloc amid Ulema Board's conditional support to MVA
- Regional rural banks must empower MSMEs via flagship govt schemes: FM Sitharaman
- Jemimah Rodrigues credits backing from Brisbane Heat teammates for classy 61-run knock
- Stalin in Virudhunagar district as part of statewide tour to monitor govt schemes
Why cheaper medicines not being promoted: Parl panel
Why cheaper medicines not being promoted: Parl panel
A parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and prices of expensive medicines pushed by pharma companies, sources said. During a meeting of the Parliamentary Standing Committee on Home Affairs, members demanded that the maximum price of COVID-19 medicines be capped, they said.
New Delhi: A parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and prices of expensive medicines pushed by pharma companies, sources said. During a meeting of the Parliamentary Standing Committee on Home Affairs, members demanded that the maximum price of COVID-19 medicines be capped, they said. Home Secretary Ajay Bhalla, Joint Secretary in Health Ministry Lav Agarwal and other officials were present in the meeting chaired by Congress leader Anand Sharma.
Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment, sources in the panel said.
The committee members expressed concern over black marketing of medicines.Naming three cheaper and easily available medicines, the committee members questioned why are they not being promoted despite being equally effective.
